Results 111 to 120 of about 22,851 (227)

Primary thromboprophylaxis in hospitalized children: A multi-center retrospective analysis.

, 2019
BACKGROUND/OBJECTIVES: Hospital acquired venous thromboembolism in children is associated with significant morbidity/mortality. Prevention strategies include sequential compression devices and prophylactic anticoagulation but these interventions carry ...
Silvey, Michael, Hall, Matt, Amos, Lauren, MD, Witmer, Char M, Carpenter, Shannon L   +4 more
core   +1 more source

When is it safe to start thromboprophylaxis after splenic angioembolization?

Thromboprophylaxis after blunt splenic trauma is complicated by the risk of bleeding, but the risk after angioembolization is unknown. We hypothesized that earlier thromboprophylaxis initiation was associated with increased bleeding complications without
Proctor, Kenneth G, O'Neil, Jr, Christopher F, Ginzburg, Enrique, Ramsey, Walter A, Meizoso, Jonathan P, Schulman, Carl I, Collie, Brianna L, Lineen, Edward B, Lyons, Nicole B, Namias, Nicholas   +9 more
core   +1 more source

Care Knowledge Translation for Thromboprophylaxis (CONECCKT-T) Investigators and the Canadian Critical Care Trials Group

, 2014
Introduction: Heparin is safe and prevents venous thromboembolism in critical illness. We aimed to determine the guideline concordance for thromboprophylaxis in critically ill patients and its predictors, and to analyze factors associated with the use of
Rodrigo Cartin-ceba, Denise Foster, Demetrios Jim Kutsogiannis, Diane Heels-ansdell, François Lauzier, Michael Jacka, Mark Crowther, Thromboprophylaxis Patterns, Éric Del, Michael J Cox, Tasnim Sinuff   +10 more
core  

Hospital thromboprophylaxis: one size should not fit all

, 2019
Venous thromboembolism, comprised of deep vein thrombosis and pulmonary embolism, is commonly found during or shortly after hospital stays. To prevent such events, processes of thromboprophylaxis have emerged for all types of inpatients through the use ...
Blondon, Marc
core   +1 more source

Anticoagulant therapy in orthopedic surgery – a review on anticoagulant agents, risk factors, monitoring, and current challenges

Journal of Orthopaedic Surgery
Orthopedic surgeries are associated with high-risk of thromboembolism which occurs in 40% to 60% of orthopedic patients in the absence of thromboprophylaxis. Conventionally heparin anticoagulants were used for thromboprophylaxis and currently direct oral
Yiqun Wang, Xiaobin Xu, Wei Zhu
doaj   +1 more source

Abstracts from the 2026 Congress of the Scandinavian Society of Anesthesiology and Intensive Care Medicine, Reykjavik, Iceland, June 10–12, 2026

Acta Anaesthesiologica Scandinavica, Volume 70, Issue 9, October 2026.
wiley   +1 more source

Thromboprophylaxis in spinal trauma surgery: consensus among spine trauma surgeons

, 2009
BACKGROUND CONTEXT: Although there are several studies evaluating the necessity and efficacy of thromboprophylaxis after spinal trauma with or without spinal cord injury (SCI), to date there is no established standard of practice pertaining to this ...
Ploumis, A., Bessey, J. T., Ponnappan, R. K., Vaccaro, A. R., Patel, R.   +4 more
core  

Orthopaedic thromboprophylaxis: limitations of current guidelines

, 2008
Thromboprophylaxis remains a controversial subject. A vast amount of epidemiological and trial data about venous thromboembolism has been published over the past 40 years.
Fisher, W.D., et, al., Dahl, O.E., Warwick, D., Wille-Jørgensen, Peer   +4 more
core   +1 more source

Venous thromboembolism in Cushing syndrome: results from an EuRRECa and Endo-ERN survey

Endocrine Connections
Background: Patients with Cushing syndrome (CS) are at increased risk of venous thromboembolism (VTE). Objective: The aim was to evaluate the current management of new cases of CS with a focus on VTE and thromboprophylaxis.
M Cherenko, N M Appelman-Dijkstra, A L Priego Zurita, N R Biermasz, O M Dekkers, F A Klok, N Reisch, A Aulinas, B Biagetti, S Cannavo, L Canu, M Detomas, F Devuyst, H Falhammar, R A Feelders, F Ferrau, F Gatto, C Grasselli, P van Houten, C Hoybye, A M Isidori, A Kyrilli, P Loli, D Maiter, E Nowak, R Pivonello, O Ragnarsson, R V Steenaard, N Unger, A van de Ven, S M Webb, D Yeste, S F Ahmed, A M Pereira   +33 more
doaj   +1 more source

Rivaroxaban as Secondary Thromboprophylaxis in Pediatric Patients With Short Bowel Syndrome. [PDF]

Case Rep Hematol
Journell AF, Peters CE, Meznarich J, Goteti S.   +3 more
europepmc   +1 more source